Search Results

Site Search

Jeff Meeusen, Ph.D., Takes a Critical Look at Trend Toward Non-Fasting Lipid Panels in Clinical Laboratory News - Insights

Jeff Meeusen, Ph.D., a clinical chemist and Co-Director of Cardiovascular Laboratory Medicine at Mayo Clinic in Rochester, recently authored an article in Clinical Laboratory News that discusses patient fasting in lipid testing. While...

Pathways Case Studies - Insights

The Pathways program provides anatomic and clinical pathology cases that include a history, potential answers, rationale, and relevant references directly from Mayo Clinic fellows, physicians, scientists, and allied health staff.

International contact information - Insights

Learn how to connect with Mayo Clinic Laboratories to discuss international testing.

Mayo Clinic Laboratories in the UnitedHealthcare Preferred Lab Network - Insights

Mayo Clinic Laboratories is pleased to announce it has been selected as a UnitedHealthcare Preferred Lab Network (PLN) care provider. Under the agreement, effective July 1, 2019, UnitedHealthcare members have in-network access to Mayo...

Autoimmune Neurology Testing - Insights

Autoimmune neurology is a rapidly evolving subspecialty driven by the discovery that the immune system can target virtually any structure within the

Next-generation sequencing - Insights

Learn more about the advantages offered by Mayo Clinic Laboratories’ next-generation sequencing panel for plasma cell neoplasms.

Advanced Crohn's monitoring test launched by Mayo Clinic - Insights

Mayo Clinic Laboratories introduces an advancement in the management of Crohn's disease with the release of a new laboratory test that measures Risankizumab levels in patients. This test will advance the therapeutic monitoring of Crohn's...

Forging ahead in the MLS Program - Insights

Elizabeth Atneosen, a student in the Mayo Clinic Medical Laboratory Science program, talks about the rewards of being in the program.

Study can improve understanding of how disability develops in MS - Insights

Mayo Clinic researchers have identified clear differences in brain and spinal cord scarring in patients with demyelinating diseases.

Antibody Prevalence in Epilepsy and Encephalopathy (APE2 ) score - Insights

Antibody Prevalence in Epilepsy and Encephalopathy (APE2 ) score.